The Global Council on Brain Health (GCBH), an independent collaborative of scientists, health professionals, scholars and policy experts from around the world who are working in areas of brain health related to human cognition concluded that there is no convincing evidence to recommend dietary supplements for brain health in healthy older adults. Consensus statements and recommendations are based on the current state of science as of May 2019 for supplements such as vitamins, caffeine, apoaequorin (jellyfish), coenzyme Q10 (CoQ10), curcumin and turmeric, flavonoids and cocoa, ginkgo biloba, huperzine-A, medium-chain triglycerides (coconut oil), melatonin, omega-3 fatty acids and fish oil, and phosphatidylserine, etc.. Supplements have not been demonstrated to delay the onset of dementia, nor can they prevent, treat or reverse Alzheimer’s disease or other neurological diseases that cause dementia. For most people, the best way to get nutrients for brain health is from a healthy diet. Unless your health care provider has identified that you have a specific nutrient deficiency, there is not sufficient data to justify taking any dietary supplement for brain health. The GCBH does not endorse any ingredient, product or supplement formulation specifically sold for brain health. Because no government agency determines dietary supplements are safe or effective before they are sold, consumers should approach supplements claiming to improve or boost brain function with skepticism. Because dietary supplements can be sold without a government agency first determining that they are safe or effective before they are sold, consumers should also be aware that in addition to being a waste of money, some supplements could physically harm them. Despite claims to the contrary, brain health supplements have not been established to maintain thinking skills or improve brain function. However, there are many lifestyle habits such as getting enough sleep, exercising regularly, eating a healthy diet, staying mentally active and being socially engaged that are recommended by the council. Source: https://www.aarp.org/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.